Production (Stage)
Twist Bioscience Corporation
TWST
$28.26
$0.100.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.23% | 24.08% | 26.53% | 27.81% | 25.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.23% | 24.08% | 26.53% | 27.81% | 25.13% |
| Cost of Revenue | 5.28% | 7.85% | 9.55% | 10.39% | 6.60% |
| Gross Profit | 49.04% | 47.92% | 55.91% | 61.09% | 66.83% |
| SG&A Expenses | 14.47% | 6.32% | 12.14% | 23.31% | 3.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.18% | 4.12% | 6.33% | 11.59% | 0.96% |
| Operating Income | 14.99% | 26.25% | 22.68% | 9.65% | 22.19% |
| Income Before Tax | 13.28% | 26.56% | 25.21% | -50.39% | 22.80% |
| Income Tax Expenses | -49.28% | -19.17% | 56.76% | -69.29% | -48.96% |
| Earnings from Continuing Operations | 13.55% | 26.54% | 25.06% | -49.09% | 23.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.55% | 26.54% | 25.06% | -49.09% | 23.10% |
| EBIT | 14.99% | 26.25% | 22.68% | 9.65% | 22.19% |
| EBITDA | 13.38% | 27.17% | 18.01% | 11.22% | 27.27% |
| EPS Basic | 16.26% | 28.61% | 26.69% | -46.26% | 24.44% |
| Normalized Basic EPS | 16.01% | 28.64% | 20.88% | 11.19% | 25.65% |
| EPS Diluted | 16.26% | 28.61% | 26.69% | -46.26% | 24.44% |
| Normalized Diluted EPS | 16.01% | 28.64% | 20.88% | 11.19% | 25.65% |
| Average Basic Shares Outstanding | 3.24% | 2.90% | 2.23% | 1.94% | 1.76% |
| Average Diluted Shares Outstanding | 3.24% | 2.90% | 2.23% | 1.94% | 1.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |